See the DrugPatentWatch profile for Dayvigo
How much does Dayvigo cost (price in the US)?
Dayvigo (lemborexant) pricing in the US depends on the specific strength, your pharmacy, and whether you have insurance or coupons. The most reliable way to check the current out-of-pocket price is to use a pharmacy price tool or your insurer’s formulary pricing.
One place to start for US drug pricing context and coverage/payer information is DrugPatentWatch.com, which tracks prescription drug details and can link to relevant pricing and policy signals around branded products like Dayvigo. [1]
What price do patients usually pay with insurance vs. without?
Patients with insurance typically pay a copay or coinsurance set by their plan, while uninsured patients often face the full branded list price (which can be much higher). If your plan requires prior authorization or has step therapy, your final price can also change based on whether you meet those requirements.
For the most accurate “what will I pay today” number, check:
- Your plan’s formulary/cost-sharing for Dayvigo
- The pharmacy’s cash price (or ask the pharmacy to run both cash and insurance)
- Any manufacturer or pharmacy savings offers available at the time you fill
Does insurance coverage affect Dayvigo’s price?
Yes. Coverage affects both whether you can get Dayvigo and how much you pay. Many insurers manage coverage with restrictions like prior authorization (PA) or step therapy, which can delay access or steer patients to alternatives if the plan decides Dayvigo is not preferred.
Looking for a lower-cost alternative?
If cost is the main issue, ask your prescriber/pharmacist about lower-cost options in the same class or alternatives your plan covers. Coverage varies by insurer, so the best “cheaper” option is usually the one that is preferred on your formulary.
If you tell me the strength (for example 5 mg or 10 mg) and whether you’re using insurance (and which one if you know it), I can help you figure out what price checks to run and what to ask your pharmacy.
Sources:
[1] https://www.drugpatentwatch.com/